Sutro Biopharma Dividends
The next dividend date for Sutro Biopharma has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Sutro Biopharma (STRO)
More About Sutro Biopharma
Sutro Biopharma, Inc. operates as a oncology company. The company develops site-specific and novel-format antibody drug conjugates (ADCs) that enables its proprietary integrated cell-free protein synthesis platform, XpressCF; and site-specific conjugation platform, XpressCF+. Its lead product candidate includes STRO-004, a tissue factor (TF) targeting ADC for the treatment of TF-expressing solid tumors, including cervical, lung, and breast cancer. The company also develops VAX-24 and Vax-31 pneumococcal conjugate vaccine candidates that is in Phase II/III clinical trials for the treatment of invasive pneumococcal disease; and STRO-003, an ADC directed against an anti-receptor tyrosine kinase-like orphan receptor 1 (ROR1) for the treatment of solid tumors, such as triple negative breast cancer, non-small cell lung cancer, and ovarian cancer, as well as hematological cancers. Sutro Biopharma, Inc. has collaboration and license agreements with Vaxcyte to discover and develop vaccine candidates for the treatment or prophylaxis of infectious diseases; Tasly Biopharmaceuticals Co., Ltd. to develop and commercialize STRO-002 in Greater China; Ipsen to develop and commercialize STRO-003, an ADC targeting ROR1; and Astellas Pharma Inc. to develop immunostimulatory ADC. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.
Owning Sutro Biopharma Stock on the Dividend Date
If you own Sutro Biopharma stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Sutro Biopharma stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Sutro Biopharma stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Sutro Biopharma stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Sutro Biopharma dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Sutro Biopharma Dividends
You can contact us any time if you would like to ask questions about Sutro Biopharma dividends or anything else related to the stock market.